KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Ratios

Cme (CME) EPS (Basic) (2016 - 2026)

Cme has reported EPS (Basic) over the past 18 years, most recently at $3.25 for Q1 2026.

  • Quarterly EPS (Basic) rose 23.57% to $3.25 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $11.8 through Mar 2026, up 18.36% year-over-year, with the annual reading at $11.18 for FY2025, 15.38% up from the prior year.
  • EPS (Basic) was $3.25 for Q1 2026 at Cme, roughly flat from $3.25 in the prior quarter.
  • Over five years, EPS (Basic) peaked at $3.25 in Q4 2025 and troughed at $1.76 in Q4 2022.
  • The 5-year median for EPS (Basic) is $2.4 (2024), against an average of $2.38.
  • Biggest five-year swings in EPS (Basic): decreased 27.8% in 2022 and later surged 35.42% in 2025.
  • Tracing CME's EPS (Basic) over 5 years: stood at $1.76 in 2022, then increased by 27.27% to $2.24 in 2023, then increased by 7.14% to $2.4 in 2024, then surged by 35.42% to $3.25 in 2025, then changed by 0.0% to $3.25 in 2026.
  • According to Business Quant data, EPS (Basic) over the past three periods came in at $3.25, $3.25, and $2.49 for Q1 2026, Q4 2025, and Q3 2025 respectively.